Senate · S 331 · 119th Congress
HALT Fentanyl Act
Sign in to cast a dissent vote.
Summary
This law permanently places all fentanyl-related substances into Schedule I, the strictest drug control category. It sets the same prison sentences for fentanyl-related drug crimes as for fentanyl itself. It also creates a faster sign-up process so researchers can more easily study these substances.
In Favor
Fentanyl and its chemical cousins have killed tens of thousands of Americans each year. Drug makers kept tweaking fentanyl's formula to create new versions that escaped the law. This bill closes that gap by banning the entire family of fentanyl-like substances at once, so traffickers cannot dodge penalties with small chemical changes.
Against
Placing an entire class of chemicals under Schedule I gives prosecutors wide reach, including over substances with little proven harm. Mandatory minimum sentences remove a judge's ability to weigh the facts of each case. Researchers and medical professionals may also face new delays or legal risk when working with substances that fall under this broad definition.
Additional Considerations
Purpose & Problem
Is the problem real and worth federal action?
The bill permanently places fentanyl-related substances as a group into Schedule I, the strictest drug control level, and sets the same penalties for these substances as for fentanyl analogues already under that law.
Scope & Related Provisions
Does it stay focused, or carry unrelated add-ons?
The bill mostly stays on its core topic, but also adds a separate process for researchers to register more easily to study Schedule I controlled substances, which goes beyond the drug scheduling change itself.
Who Is Affected
Who benefits, and who bears the cost?
People caught with or trafficking fentanyl-related substances face the existing mandatory minimum prison terms. Researchers at federal agencies or those with federal funding gain a faster path to approval for studying these substances.
Cost & Funding
Is it affordable and responsibly funded?
The bill does not authorize or appropriate a specific dollar amount. It shifts duties onto the Attorney General to write new rules within six months and to process researcher registrations, which creates new workload for federal agencies.
Risks & Implementation
What could go wrong in practice?
The bill defines fentanyl-related substances by chemical structure, so determining whether a new substance meets that definition requires ongoing chemical analysis by enforcement agencies. The Attorney General must also issue rules within six months, which sets a tight deadline for a complex task.
For the actual bill text, see congress.gov.
AI-generated · Published 5/31/2026